Prenatal Testing: The Importance of Early Preeclampsia and Genetic Screening in Pregnancy
April 28, 2025
Early preeclampsia and genetic screening in pregnancy can identify conditions that may increase risk for fetal and maternal complications. Insights from these screenings can help your patients better prepare for the future.
In our webinar, you'll learn how early preeclampsia screening and the latest developments in cell-free DNA (cfDNA) noninvasive prenatal testing (NIPT) can help you improve maternal and perinatal outcomes.
Speakers
Kelly Curd, MS, MEd, CGC
Medical Science Liaison, Women’s Health and Genetics, Labcorp
Cornelia R. Graves, MD, FACOG
Medical Director and Managing Partner, Tennessee Maternal Fetal Medicine
Director of Perinatal Services, St. Thomas Health